InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Aghazadeh Behzad, 董事. Insider active across 2 companies, notably Aadi Bioscience, Inc.. Aggregated, 5 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €31.8m. Activity tracked since 26 August 2021. The latest transaction was disclosed on 28 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Aghazadeh Behzad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
7,905 股@ US$18.250.4% 占其流量Common Stock, par value $0.0001 per shareSEC:0000902664-26-003270:2
标准退出：2026年10月26日 (T+90)
2,333,333 股@ US$15.0096.5% 占其流量Common Stock, par value $0.0001 per shareSEC:0000902664-26-003270:0
标准退出：2026年10月22日 (T+90)
50,000 股@ US$22.313.1% 占其流量Common Stock, par value $0.0001 per shareSEC:0000902664-26-003270:1
标准退出：2026年10月22日 (T+90)
1,260,000 股@ US$12.5027.3% 占其流量Common Stock, $0.0001 par value per share ("Common Stock")SEC:0000902664-22-004356:0
1,911,752 股@ US$13.07757.1% 占其流量Common Stock, $0.0001 par value per share ("Common Stock")SEC:0000902664-21-004071:0
5 条申报中的 5 条
About Aghazadeh Behzad
Behzad Aghazadeh serves as a Director at Aadi Bioscience, Inc. In this role, he participates in the governance of the company by contributing to strategic decision-making and performance oversight. With experience in the biopharmaceutical sector, Behzad provides valuable insights that help guide the company's initiatives. His commitment to innovation and research is fundamental to Aadi Bioscience's success.
